These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3112014)

  • 41. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites.
    Malo D; Vogan K; Vidal S; Hu J; Cellier M; Schurr E; Fuks A; Bumstead N; Morgan K; Gros P
    Genomics; 1994 Sep; 23(1):51-61. PubMed ID: 7829102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution of cell types and T-cell subsets in the spleens of Mycobacterium bovis BCG-resistant and M. bovis BCG-susceptible strains of mice after infection with M. bovis BCG.
    Denis M; Forget A; Miailhe AC; Pelletier M; Skamene E
    Infect Immun; 1985 Jul; 49(1):253-5. PubMed ID: 3891628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
    Lecoeur HF; Lagrange PH; Truffot-Pernot C; Gheorghiu M; Grosset J
    Clin Exp Immunol; 1989 Jun; 76(3):458-62. PubMed ID: 2502336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice.
    Fortier AH; Mock BA; Meltzer MS; Nacy CA
    Infect Immun; 1987 Jul; 55(7):1707-14. PubMed ID: 3298065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs.
    Hernandez-Frontera E; McMurray DN
    Infect Immun; 1993 May; 61(5):2116-21. PubMed ID: 8478101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancing effect of passive immunization with mycobacterial antibodies on humoral and cellular immunity in BCG-infected mice.
    Forget A; Turcotte R; Benoit JC; Borduas AG
    Ann Immunol (Paris); 1978; 129(2-3):255-65. PubMed ID: 98097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.
    Olleros ML; Guler R; Corazza N; Vesin D; Eugster HP; Marchal G; Chavarot P; Mueller C; Garcia I
    J Immunol; 2002 Apr; 168(7):3394-401. PubMed ID: 11907097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavior of attenuated mycobacteria in organs of neonatal and adult mice.
    Costello RT; Izumi T; Sakurami T
    J Exp Med; 1971 Aug; 134(2):366-80. PubMed ID: 4934501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele.
    Govoni G; Vidal S; Gauthier S; Skamene E; Malo D; Gros P
    Infect Immun; 1996 Aug; 64(8):2923-9. PubMed ID: 8757814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.
    Delogu G; Li A; Repique C; Collins F; Morris SL
    Infect Immun; 2002 Jan; 70(1):292-302. PubMed ID: 11748195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Bcg gene (Nramp1) does not determine resistance of mice to virulent Mycobacterium tuberculosis.
    Medina E; North RJ
    Ann N Y Acad Sci; 1996 Oct; 797():257-9. PubMed ID: 8993372
    [No Abstract]   [Full Text] [Related]  

  • 54. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
    Heldwein KA; Liang MD; Andresen TK; Thomas KE; Marty AM; Cuesta N; Vogel SN; Fenton MJ
    J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal development of resistance to pulmonary tuberculosis in Swiss albino mice.
    Izumi T; Costello R
    J Exp Med; 1971 Feb; 133(2):376-88. PubMed ID: 5002520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
    Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
    Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation.
    Thompson-Snipes L; Skamene E; Radzioch D
    Infect Immun; 1998 Nov; 66(11):5268-74. PubMed ID: 9784532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
    Lagrange PH
    Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
    [No Abstract]   [Full Text] [Related]  

  • 60. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.
    Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I
    J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.